https://assets.capyfin.com/instruments/678fdc13234e27009c5d5e54.png avatar
Ascendis Pharma
🇩🇰 NASDAQ:ASND

Ascendis Pharma Q4 2024 Earnings Report

Total Revenue
$186M
Previous year: $148M
+25.2%
EPS
-$0.68
Previous year: -$1.66
-59.0%

Ascendis Pharma Revenue

Ascendis Pharma EPS